Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1994 of 5804
-
New antibody drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agents
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Mindful moms: yoga may lift depression in pregnancy
Symptom relief Recruiting nowThe purpose of this study is to test whether a program called "Mindful Moms" can be helpful for specific measures of mood and health in pregnant women with depressive symptoms, compared to group-based education workshops.
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New biomarkers could speed up pneumonia diagnosis in ICU patients
Diagnosis Recruiting nowThe purpose of this study is to evaluate different peptide biomarkers, variations in the microbiome and patterns in the bacterial transcriptome as prognostic or diagnostic biomarkers of VAP.
Sponsor: Region Skane • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
Home-Based balance training shows promise for MS and Parkinson's patients
Symptom relief OngoingThe goal of this one blind-randomized controlled clinical trial is to evaluate the clinical effectiveness of a telerehabilitation (TR) protocol focusing on balance rehabilitation in patients with neurodegenerative diseases (Parkinson's Disease, Multiple Sclerosis). The secondary…
Phase: NA • Sponsor: IRCCS San Camillo, Venezia, Italy • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Fabrazyme shows promise for fabry disease in chinese study
Disease control CompletedThis is a 54-week Phase 4, open label, single arm study to evaluate the safety and the efficacy of Fabrazyme (agalsidase beta) as enzyme replacement therapy (ERT) in Chinese participants with Fabry Disease.
Phase: PHASE4 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 26, 2026 15:35 UTC
-
Remote workouts show promise for long COVID relief
Symptom relief CompletedPatients with long coronavirus disease (COVID-19) experience multisystem symptoms and reduced quality of life (QOL). Proactive interventions are needed to enhance health outcomes.To investigate the effects of a 12-week tele-exercise training program on long COVID symptoms, cardio…
Phase: NA • Sponsor: Tri-Service General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Aspirin and diet may fight cancer return
Disease control CompletedTo learn if lifestyle changes (such as diet and exercise) combined with daily aspirin and vitamin D can affect the likelihood of advanced colorectal cancer coming back (recurring)
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New study tests safer refeeding for teens with atypical anorexia
Disease control ENROLLING_BY_INVITATIONThe primary purpose of the trial is to compare the efficacy and safety of Individualized Caloric Refeeding (ICR) to the new standard of care, Higher Calorie Refeeding (HCR), in hospitalized patients with atypical anorexia nervosa (AAN), and clinical remission over one year of fol…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a simple blood test guide steroid use in COPD emergencies?
Disease control TerminatedThe primary objective of this study is to compare treatment failure rates between a group of eosinophilic (eosinophilia \> 2% on day 1 of hospitalization) patients hospitalised for a COPD exacerbation treated via corticotherapy versus a similar group treated via placebo. Seconda…
Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for endometriosis sufferers: drug trial targets severe pain
Symptom relief CompletedThis study is designed to evaluate the safety and efficacy of HMI-115 compared to placebo over a 12 weeks period on subjects with moderate to severe endometriosis-associated pain.
Phase: PHASE2 • Sponsor: Hope Medicine (Nanjing) Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could shockwaves and magnets ease lymphedema? new trial aims to find out
Symptom relief Recruiting nowLymphedema occurs not only in patients with breast cancer and gynecological cancers but also in those where lymphatic drainage is obstructed. Accumulation of lymphatic fluid within tissues results in limb swelling. Additionally, proteins present in lymphatic fluid might lead to f…
Phase: NA • Sponsor: Zheng-Yu Hoe, MD., PhD. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New depression combo drug shows promise in large safety trial
Symptom relief CompletedThis is a multicenter, open-label, fixed dose, 26 week study of patients with MDD. Eligible patients from the lead-in studies will enter the Open-label Safety Study at the Screening/Baseline Visit (Visit 1/Day 1), at which point patient eligibility will be assessed and informed c…
Phase: PHASE3 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Could skipping a common painkiller improve cancer pain treatment?
Symptom relief Recruiting nowEndoscopic ultrasound (EUS) allows EUS-guided trans gastric injection of absolute alcohol around the base of the celiac plexus (celiac plexus neurolysis (EUS-CPN)), to help alleviate pain associated with pancreatic cancer. It is standard procedure to inject bupivacaine immediate…
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can an online program ease the distress of unexplained physical symptoms?
Symptom relief CompletedThe annual societal cost of medically unexplained symptoms in Sweden is approximately 40 billion SEK, i.e., similar to the annual cost of cancer. Prevalent chronic diseases like asthma and diabetes are also commonly associated with somatic symptoms that lead to significant distre…
Phase: NA • Sponsor: Region Stockholm • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Real-world data may reveal true value of abemaciclib for advanced breast cancer
Disease control Recruiting nowThe present study will assess real-world clinical outcomes and adverse events from treatment with endocrine therapy combined with abemaciclib in patients with HR-positive, HER2-negative advanced breast cancer.
Sponsor: Hellenic Cooperative Oncology Group • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New combo therapy for tough melanoma shows promise but trial halted early
Disease control TerminatedThis trial is a Phase I/II study in which a combination of duvelisib and nivolumab will be used to treat a total of patients diagnosed with advanced unresectable melanoma who have progressed on anti-PD1 therapy. The Recommended Phase II Dose of oral duvelisib will be determined a…
Phase: PHASE1, PHASE2 • Sponsor: John Kirkwood • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a higher oxytocin dose reduce C-Sections in obese women?
Disease control CompletedThe rate of caesarean section is higher among obese pregnant women, leading to increased morbidity in this already vulnerable population. Oxytocin is the main drug used in obstetrics to optimize progress of labour, but observational studies have suggested that its efficiency may …
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Sleep study could unlock secrets of Parkinson's progression
Knowledge-focused Recruiting nowBioFINDER-Sleep study was established in 2021 and will include patients with early Parkinson´s disease (PD) and persons with iRBD to provide essential insights into the underlying mechanisms of the progressive neurodegenerative processes in central and peripheral nervous systems.…
Sponsor: Skane University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Could 10 days of brain zaps ease ADHD in teens?
Symptom relief OngoingThe objective of this clinical trial is to examine whether non-invasive brain stimulation can modulate dysfunctional brain dynamics underlying adolescent ADHD to subsequently improve clinical symptoms.
Phase: NA • Sponsor: Bradley Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 15:16 UTC
-
Does cannabis fuel aggressive lung cancer in young adults?
Knowledge-focused Recruiting nowCannabis is the most consumed drug in the world and the French are the main consumers in Europe. The most recognized effects of cannabis on human health are of a neuro-psychic nature. The medical literature on the effects of cannabis on the lung in general, and on lung carcinogen…
Phase: NA • Sponsor: Centre Chirurgical Marie Lannelongue • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC